A Personal Experience with COVID-19 with Dr Noopur Raje
Oncology Today with Dr Neil Love
Dr Noopur Raje from Massachusetts General Hospital (MGH) discusses her personal experience after testing positive for COVID-19 and caring for her husband, who was hospitalized with the disease. She also talks about how patients with multiple myeloma, including those receiving CAR T-cell therapy, are being treated at MGH. References Gosain R et al. COVID-19 and cancer: A comprehensive review. Curr Oncol Rep 2020;22(5):53. Abstract Malard F, Mohty M. Management of patients with multiple myeloma during the COVID-19 pandemic. Lancet Haematol 2020;7(6):e435-e437. Abstract Saleh A et al. Multiple myeloma in the time of COVID-19. Acta Haematol 2020;143(5):410-6. Abstract Sharpless N et al. COVID-19 and cancer. Science 2020;368(6497):1290. Abstract Weinkove R et al. Managing haematology and oncology patients during the covid-19 pandemic: Interim consensus guidance. Med J Aust 2020;212(10):481-9. Abstract
Myeloma Crowd Radio: Noopur Raje, MD, Massachusetts General Hospital
Myeloma Crowd Radio
CAR T therapy has been in development for over 20 years. The first CAR T therapy is now available for the treatment of multiple myeloma. The ide-cel treatment (now called Abecma) is now FDA approved for multiple myeloma relapsed or refractory patients. In this show, Dr. Noopur Raje of Mass General Hospital will share how the CAR T cell therapy works, outcome data from clinical trials, a review of patients who are eligible to join and when patients should consider the therapy in context of other therapies. Ide-cel (Abecma) is a product developed by Bristol Myers Squibb and blubird bio. Thanks to our episode sponsor, Oncopeptides
ASCO Hem 2019 Interviews | Interview with Noopur Raje, MD
Hematologic Oncology Update
A special audio supplement to a CME symposium held at the 2019 ASCO Annual Meeting featuring expert comments on the application of emerging research to patient care. Interview with Noopur Raje, MD conducted by Neil Love, MD. Produced by Research To Practice.
Breaking the Mold to Improve Multiple Myeloma Treatment with Noopur Raje
Charged: Stories from the Women Leading Health Care
In 2005 Noopur Raje, MD, came to the Mass General Cancer Center with a plan to establish a new type of lab dedicated to the study of multiple myeloma, a cancer that affects the plasma cells and weakens bones. Like any uncharted territory, establishing this narrowly-focused lab required some tenacity. Noopur was up to the task, working hard to build a successful research program that has expanded our understanding of this cancer. Today, Dr. Raje directs the Center for Multiple Myeloma at the Mass General Cancer Center. In this episode, she discusses why she thinks risk-taking is important to success and how she draws inspiration from her patients to keep pressing forward.
Pogress in the Treatment of Multiple Myeloma - An Interview with Dr. Noopur Raje
The Onco'Zine Brief
In this edition of The OncoZine Brief, Peter Hofland, Ph.D and Sonia Portillo review some of the interesting studies presented at the 59th annual meeting of the American Society of Hematology – which took place December 9 – 12, 2017 in Atlanta, Georgia.They recap one of the most important healthcare conferences of the year, the annual meeting American Society of Hematology or ASH, one of these ‘must go to’ meetings for oncology and hematology specialists but also for oncology nurses, researchers, and patients alike. In this episode they also interview Noopur Raje, MD, Associate Professor of Medicine at Harvard Medical School; Director of the Multiple Myeloma Center at Massachusetts General Hospital Boston, MassachusettsDr. Raje is associate professor of medicine at Harvard Medical School and director of the Multiple Myeloma Center at Massachusetts General Hospital. She spearheads a translational research program evaluating novel therapeutics in myeloma with a special interest in the biology of myeloma bone disease.Dr. Raje is a member of the International Myeloma Working Group and NCCN Clinical Practice Guidelines Committee for Multiple Myeloma. Massachusetts General Hospital.
Clinical Investigator and Nursing Perspectives on the Management of Common Cancers. Multiple Myeloma Edition. Interview with Noopur Raje, MD conducted by Neil Love, MD. Produced by Research To Practice.